Member Info for The.Italian

Specimen,90% for a contractual offer and 75% if achieved by scheme of arrangementhttps://resourcehub.bakermckenzie.com/en/resources/global-public-ma-guide/europe-middle-east-and-africa/united-kingdom/topics/effecting-a-takeover

Another tweet yesterday referencing the "product launch" so it does suggest a new product (or more probably a new version of the current product). anyway,just mentioning it in case anyone is interested.

On a slightly tangential point re manufacturing,the inference i draw from borders webcast with proactive today,is that the current/pre_existing capacity is not adequate, hence the second manufacturer now appointed,and the clear reference to a third being required in due course.i assume the new one will need to satisfy quality requirements etc,so may be a little while before it is in actual production,but clearly fum are focussed on ensuring that the manufacturing capability will be up to scratch asap.

Thanks etclescake. im well aware that senclock has been out for some time and i have viewed previous presentations.what i have assumed (i may of course be wrong) is that this a new/improved or more specialised .version being senoclock gold.as i said yesterday i can't view the tweet,so its just surmise on my part, but i don't recall the "gold" tag being used before. as always happy to be corrected if it has.

Yes,thanks for the info re holden's programme.personally i think that is superb publicity. will be interestingvto see if it actually features in the broadcasts,which would be even better.

Just in case anyone is interested,there was a tweet yesterday from DLI referring to the launch of senoclock gold.the blurb refers to "designed to empower your workforce with personalised health and wellness insights", whatever that means. i 'm not on twitter so can't read it, but looks as though it is aimed at employers. doubt it is of any real significance in the overall scheme of things.

I've just managed to access it on my phone(as opposed to my laptop)so will listen this evening with interest.

Laguito and krull.many thanks for the posts.i was still puzzled before krill's post as i listened again and couldnt find it on the you tube webcast.unfortunately i can't view the investor centre one posted by krull due to a problem with my browser.if anyone can post an alternative link (not through future investor centre) i would be grateful.

Bit too soon for them to comment imo.i do expect something first thing tomorrow though.

Well i have listened to the webcast and i'm afraid(actually im glad) that i didn't hear anything to support the suggestion that futura have any current plans to embark on trials for med 3000 in the area of female sexual health. the sound quality was rather poor,so i may have missed something,but my main take was that fum are currently concentrating(quite rightly imo) on the roll out of med 3000 in its current form. barder mentioned this as the main focus several times,emphasising that the aim was to move from a loss making company to one with positive profit,an objective ofter sadly lacking in many aim companies. in a slightly different context,when responding to a question as to whether fum would contemplate acquiring another aim company(sorry didn't catch the name) which was suggested as being a good fit, barder made it very clear that the did not wish to see them encumbered with debt when they were on the point of becoming csh positive,again a very sensible point of view.he also commented that fum is, in reality,a very small company. further trials etc were clearly not on the current agenda.pleased to hear that australia should get approval without further trials and perhaps we may hear more on this by end of year. so all in all i really don't see any developments of substance in other areas as likely for quite some time.

Thanks for the link,Krull. appreciated. i will have a listen this evening.

Yes,it's all very interesting,but where are the actual links to fum saying all this,or even part of it?can you please post actual links,rather than cut and paste or ostensible"quotes"

Yes ,i think potentially it could be a takeover target. i posted a few days ago,that this might be a welcome outcome for the board for various reasons.however,i think it is going to need a much longer data period re sales etc,before this becomes a realistic possibility.18 months to 2 years at a minimum i would have thought.just my opinion of course.

Excellent news potentially.still deep in the woods,but is there a glimpse of sunlight appearing?time will tell.

Hello dougie,i certainly don't have any expertise in the technicalities of the fda approval process and the challlenges facing fortacin in the US. my" longshot" comment is based on nothing more than the continuing failure to announce SPA agreement,despite several optimistic statements suggesting it was close (my interpretation of their announcements).i completely agree that there has been no statement of a problem, so i may be pleasantly surprise by good news at some point,but i have been waiting hear about the progress for several months now and the failure to provide any detailed update in the recent results is now suggesting to me that there is a problem which they won't disclose.i do hope im wrong and, of course, this is just my personal inference drawn form the delay etc..as i say,let's hope im being unduly pessimistic.

Hello keith and bignose.still here.just not been a great deal to write about.i checked the news for DLI which i do most days,but nothing there today.yes should get china news of submission fairly soon.FDA is looking a very long shot now,but you never know. keeping fingers crossed as usual!

Interesting news,thanks. it is encouraging to see the roll out continue..

Not surprising, but profoundly cynical and self serving. par for the course i'm afraid.

Yes, look much as expected, confirming the basic solidity of the group. main point for me is the fairly significant debt reduction, which, in these times of increasing finance cost, is clearly very important.

Ah ah. i can see i was well behind the curve.didntrealise there had been news on friday eveninghttps://www.reuters.com/markets/deals/us-ftc-allows-amgen-move-forward-with-278-bln-horizon-deal-cnbc-2023-09-01/ perhaps an uptick on monday?